otriga Granular Capsules special drug use surveillance (long-term use survey)
Not Applicable
- Conditions
- Hyperlipidemia
- Registration Number
- JPRN-jRCT1080222407
- Lead Sponsor
- TAKEDA PHARMACEUTICAL COMPANY LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 3084
Inclusion Criteria
Patients with hyperlipidemia
Exclusion Criteria
(1) Patients with hemorrhage (e.g., hemophilia, capillary fragility, gastrointestinal ulcer, urinary tract hemorrhage, hemoptysis, or vitreous hemorrhage)
(2) Patients with a history of hypersensitivity to ingredients in Lotriga Granular Capsules
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method